107 (Rabeprazole sodium 20 mg)
Pill imprint 107 has been identified as Rabeprazole sodium 20 mg.
Rabeprazole is used in the treatment of gerd; barrett's esophagus; erosive esophagitis; zollinger-ellison syndrome; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 107
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Torrent Pharmaceuticals Limited
More about rabeprazole
Consumer resources
- Rabeprazole delayed-release capsules
- Rabeprazole delayed-release tablets
- Rabeprazole
- Rabeprazole (Advanced Reading)
- Other brands: Aciphex, Aciphex Sprinkle
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
